TL;DR
This paper introduces a novel method for rapidly tagging and purifying endogenous human proteins using CRISPR-Cas9 gene editing and fluorescence-activated cell sorting (FACS). This approach was successfully applied to determine high-resolution cryo-EM structures of the human PA28-20S proteasome, revealing its subunit stoichiometry and substrate entry mechanism.
What Problem Does This Paper Address?
Structural biology, especially for complex and biomedically important targets like membrane proteins and large macromolecular assemblies, is often hampered by the difficulty of producing functional, folded proteins. Traditional overexpression methods can lead to misfolded, nonfunctional, or degraded proteins, and assembling multi-protein complexes is particularly challenging. While purifying proteins from native sources is an alternative, it's often limited to highly abundant proteins. The authors aim to provide a general, efficient, and rapid method to tag and purify endogenous proteins from human cells for structural characterization, overcoming these limitations.
Methods
The core of the methodology is a combination of two key techniques:
- CRISPR-Cas9 Gene Editing with Split Fluorescent Proteins (FP11-StrepII tag): The researchers used CRISPR-Cas9 to introduce a small, split fluorescent protein tag (FP11) fused to a purification tag (StrepII) into the endogenous gene of interest. The FP11 tag is a fragment of a fluorescent protein that can spontaneously complement with another fragment (FP1-10) to form a functional fluorescent protein.
- Fluorescence-Activated Cell Sorting (FACS): After introducing the FP11-StrepII tag and transiently expressing the FP1-10 fragment, cells that successfully incorporated the tag exhibit fluorescence. FACS is then used to rapidly isolate these "knock-in positive" cells. Crucially, the FP1-10 fragment is designed to be transiently expressed and depleted over time, ensuring that the final purified protein only carries the small FP11-StrepII tag, minimizing structural interference.
- Affinity Purification and Cryo-EM: Once the tagged endogenous protein is purified using the StrepII tag, it's subjected to cryogenic electron microscopy (cryo-EM) for high-resolution structural determination.
This pipeline allows for rapid tagging, purification, and structural analysis of endogenous protein complexes, bypassing the need for extensive single-cell clonal selection and lengthy optimization of overexpression systems.
Datasets
Not discussed in the paper.
Key Insights and Ideas
- Efficient Endogenous Protein Tagging: The combination of CRISPR-Cas9 and split fluorescent proteins provides a powerful and rapid way to tag endogenous proteins, making structural studies of challenging targets more accessible.
- PA28-20S Proteasome Stoichiometry: The study revealed a novel subunit stoichiometry for the endogenous human PA28αβ–20S proteasome as 3α/4β, differing from previously reported 4α/3β stoichiometry in heterologously expressed systems. This suggests that native assembly mechanisms may favor a different composition.
- Substrate Entry Mechanism: The cryo-EM structures provide visual evidence of how unfolded polypeptides enter the proteasome. Hydrophilic peptides (like the ALFA peptide used for purification) were observed in the antechamber of the 20S proteasome, suggesting they are held there before entering the proteolytic chamber for degradation. This implies a controlled entry process.
- Tight Engagement of PA28 with 20S: The high-resolution structures demonstrate that the endogenous PA28 engages very tightly with the 20S proteasome, with six out of seven C termini of PA28 making stable interactions with the 20S α-ring binding pockets. This tight interaction may contribute to the observed 3α/4β stoichiometry.
- Decoupled Proteolysis and Substrate Movement: Experiments with the proteasome inhibitor MG-132 suggest that while proteolysis can be blocked, the movement of peptide-like molecules within the proteasome's chambers is not significantly impeded, indicating these processes can occur independently.
Key Results
- The developed method enabled the rapid determination of cryo-EM structures of several human proteasomal complexes, including PA28–20S, PA200–20S, and 19S–20S, at resolutions ranging from ~2.6 to ~3.2 Å.
- A high-resolution structure of the intact human PA28αβ–20S complex was obtained, revealing a 3α/4β subunit stoichiometry.
- The study demonstrated the ability to multiplex orthogonal tags (mNG2[11]-StrepII and sfCherry2[11]-ALFA) onto different subunits of the proteasome to increase target specificity.
- Observations of ALFA peptide density within the 20S antechamber provided insights into substrate loading and movement.
Limitations and Future Work
- PA28 Stoichiometry Ambiguity: While the study strongly suggests a 3α/4β stoichiometry for endogenous PA28αβ–20S, the authors acknowledge that the data do not entirely discount the possibility of other PA28 configurations (e.g., 4α/3β) being present in the cell. Cryo-EM classification biases might have excluded weakly interacting complexes.
- Future Directions: The authors envision this approach being broadly applicable to studying many important endogenous human macromolecular complexes. They highlight the potential for applying this strategy to disease models to study proteins in their physiological states and gain insights into disease mechanisms. Further development of efficient strategies to tag and purify low-expressing proteins and to target native proteins from animal models is also suggested.
Summary updated